A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors

NCT00268905 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: E7389 + carboplatin AUC 5
DRUG: E7389 + carboplatin AUC 6
DRUG: E7389+carboplatin AUC 6

Sponsor

Eisai Inc.